March 19, 2026—iVascular announced 1-year results from the BARISTA clinical trial, which is evaluating the safety and efficacy of the company&rs ...
For patients with iliac artery blockages, treatment with a self-expanding stent provides better protection against restenosis at 12 months and no reduction in safety compared with a balloon-expandable ...
The Revello™ Vascular Covered Stent is designed to combine the flexibility of a nitinol self-expanding stent with the radial ...
Several balloon-expandable stents have been used in the iliac artery, however, they have not had a primary indication for iliac stenting. The Express® LD iliac premounted stent system (Boston ...
Vascular. 2007;15(1):5-11. According to Ballard and colleagues, factors such as female sex, superficial femoral artery occlusion, perioperative vascular complications, and hypercholesterolemia proved ...
Stenting of iliac artery disease in patients with severely calcified lesions or extensive peripheral artery disease (PAD)—who historically have been excluded from clinical trials—is safe and effective ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained ...
ABBOTT PARK, Ill., Aug. 7, 2012 /PRNewswire/ -- Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite ® Vascular Balloon-Expandable Stent System for the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients who underwent primary stenting guided by IVUS ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...
The US Food and Drug Administration (FDA) has approved Abbott's Absolute Pro Vascular Self-Expanding Stent System for the treatment of iliac artery disease, a form of peripheral artery disease (PAD) ...
BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results